3 ms·
> A similar study (HPTN 083) in HIV-uninfected cisgender men who have sex with men and transgender women who have sex with men, was also stopped early by its DS
by msla 6y ago
> A similar study (HPTN 083) in HIV-uninfected cisgender men who have sex with men and transgender women who have sex with men, was also stopped early by its DSMB in May 2020, after it also demonstrated that CAB LA was highly effective in preventing HIV acquisition in this group.
So it works on people who are physiologically male, too, but this study seems to have been specifically about people who are physiologically female. (I guess. They don't mention results for trans men, so I don't know if they're neglecting that group or what's going on there.)
- valarauko 6y ago>They don't mention results for trans men, so I don't know if they're neglecting that group or what's going on there Might just be an issue with recruiting enough statistically sufficient numbers of trans men for the study group.
- heavyset_go 6y agoThere are other trials for HIV vaccines in the US that are recruiting MSM, and some that are specifically recruiting trans people.